Analysis of the relationship between viral infection and autoimmune disease.

[1]  E. Ward,et al.  Negative Selection during the Peripheral Immune Response to Antigen , 2001, The Journal of experimental medicine.

[2]  C. Klein,et al.  Comparative Analysis of Genetically Modified Dendritic Cells and Tumor Cells as Therapeutic Cancer Vaccines , 2000, The Journal of experimental medicine.

[3]  M. Atkinson,et al.  Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. , 2000, Diabetes.

[4]  F. Rodríguez,et al.  Virus-Induced Diabetes in a Transgenic Model: Role of Cross-Reacting Viruses and Quantitation of Effector T Cells Needed To Cause Disease , 2000, Journal of Virology.

[5]  B. Rouse,et al.  Bystander activation of CD4+ T cells accounts for herpetic ocular lesions. , 2000, Investigative ophthalmology & visual science.

[6]  B. Ludewig,et al.  Role of dendritic cells in the induction and maintenance of autoimmune diseases , 1999, Immunological reviews.

[7]  N. Sarvetnick,et al.  Viruses, host responses, and autoimmunity , 1999, Immunological reviews.

[8]  J. Daley,et al.  Inactivation of misselected CD8 T cells by CD8 gene methylation and cell death. , 1999, Science.

[9]  T. Gura.  Chlamydia Protein Linked to Heart Disease , 1999, Science.

[10]  J. Penninger,et al.  Chlamydia infections and heart disease linked through antigenic mimicry. , 1999, Science.

[11]  B. Rouse,et al.  Virus-induced immunoinflammatory lesions in the absence of viral antigen recognition. , 1998, Journal of immunology.

[12]  C. Janeway,et al.  Innate immune recognition and control of adaptive immune responses. , 1998, Seminars in immunology.

[13]  J. Bluestone,et al.  The functional significance of epitope spreading and its regulation by co‐stimulatory molecules , 1998, Immunological reviews.

[14]  A. Steere,et al.  Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. , 1998, Science.

[15]  C. Kurts,et al.  Brief Definitive Report Major Histocompatibility Complex Class I–restricted Cross-presentation Is Biased towards High Dose Antigens and Those Released during Cellular Destruction , 2022 .

[16]  Troy Krahl,et al.  Diabetes induced by Coxsackie virus: Initiation by bystander damage and not molecular mimicry , 1998, Nature Medicine.

[17]  H Cantor,et al.  Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. , 1998, Science.

[18]  S. Miller,et al.  Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading , 1997, Nature Medicine.

[19]  M. Dana,et al.  Immunity causing blindness: five different paths to herpes stromal keratitis. , 1997, Immunology today.

[20]  Moses Rodriguez,et al.  Primary demyelination in transgenic mice expressing interferon-γ , 1997, Nature Medicine.

[21]  R. Zinkernagel,et al.  Peptide‐induced T cell receptor down‐regulation on naive T cells predicts agonist/partial agonist properties and strictly correlates with T cell activation , 1997, European journal of immunology.

[22]  B. Rouse,et al.  Suppression of ongoing ocular inflammatory disease by topical administration of plasmid DNA encoding IL-10. , 1997, Journal of immunology.

[23]  Bernhard Hemmer,et al.  Identification of High Potency Microbial and Self Ligands for a Human Autoreactive Class II–restricted T Cell Clone , 1997, The Journal of experimental medicine.

[24]  R. Zinkernagel,et al.  Bystander Activation of Cytotoxic T Cells: Studies on the Mechanism and Evaluation of In Vivo Significance in a Transgenic Mouse Model , 1997, The Journal of experimental medicine.

[25]  B. Rouse,et al.  On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis. , 1997, Journal of immunology.

[26]  G. Kollias,et al.  Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. , 1997, Journal of immunology.

[27]  M. Oldstone,et al.  Virus-induced autoimmune disease , 1996, Current Opinion in Immunology.

[28]  A. Davison,et al.  Isolation and characterization of herpes simplex virus type 1 mutants defective in the UL6 gene. , 1996, Virology.

[29]  C. Foster,et al.  Resistance to herpes stromal keratitis conferred by an lgG2a-derived peptide , 1995, Nature.

[30]  S. Miller,et al.  Evolution of the T‐Cell Repertoire during the Course of Experimental Immune‐Mediated Demyelinating Diseases , 1995, Immunological reviews.

[31]  J. Strominger,et al.  Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein , 1995, Cell.

[32]  F. Alt,et al.  Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus. , 1993, International immunology.

[33]  V. Stewart,et al.  RAG-2-deficient blastocyst complementation: an assay of gene function in lymphocyte development. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[34]  L. Hood,et al.  Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity , 1993, Cell.

[35]  Ji-Woon Yoon,et al.  Studies on Autoimmunity for T-Cell-Mediated β-Cell Destruction: Distinct Difference in β-Cell Destruction Between CD4+ and CD8+ T-Cell Clones Derived From Lymphocytes Infiltrating the Islets of NOD Mice , 1992, Diabetes.

[36]  H. Pircher,et al.  Ablation of “tolerance” and induction of diabetes by virus infection in viral antigen transgenic mice , 1991, Cell.

[37]  T. Tumpey,et al.  Contribution of virus and immune factors to herpes simplex virus type I-induced corneal pathology. , 1990, Investigative ophthalmology & visual science.

[38]  J. Oakes,et al.  Ocular avirulence of a herpes simplex virus type 1 strain is associated with heightened sensitivity to alpha/beta interferon , 1990, Journal of virology.

[39]  V. Tuohy,et al.  Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease☆ , 1990, Journal of Neuroimmunology.

[40]  H. Pircher,et al.  Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen , 1989, Nature.

[41]  M. Frohman,et al.  Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[42]  M. Oldstone.  Molecular mimicry and autoimmune disease , 1987, Cell.

[43]  M. Greene,et al.  Previous immunization of mice with herpes simplex virus type-1 strain MP protects against secondary corneal infection. , 1986, Clinical immunology and immunopathology.

[44]  J. Monroe,et al.  Genetic studies on murine susceptibility to herpes simplex keratitis. , 1986, Clinical immunology and immunopathology.

[45]  W. Sibley,et al.  CLINICAL VIRAL INFECTIONS AND MULTIPLE SCLEROSIS , 1985, The Lancet.

[46]  D. Altmann,et al.  Protection from herpes simplex virus-induced neuropathology in mice showing delayed hypersensitivity tolerance. , 1985, The Journal of general virology.

[47]  D. Linthicum,et al.  Acute experimental autoimmune encephalomyelitis in mice. I. Adjuvant action of Bordetella pertussis is due to vasoactive amine sensitization and increased vascular permeability of the central nervous system. , 1982, Cellular immunology.

[48]  M. D. Dal Canto,et al.  Experimental models of virus‐induced demyelination of the central nervous system , 1982, Annals of neurology.

[49]  D. R. Gamble.  Relation of antecedent illness to development of diabetes in children. , 1980, British medical journal.

[50]  D. R. Gamble,et al.  Coxsackie B virus and diabetes. , 1973, British medical journal.

[51]  C HISCOCK,et al.  YELLOW NAILS AND LYMPHOEDEMA. , 1964, Lancet.

[52]  H. Cantor,et al.  T-cell receptor crossreactivity and autoimmune disease. , 2000, Advances in immunology.

[53]  R. Zinkernagel,et al.  CD4+ T-cell induction and effector functions: a comparison of immunity against soluble antigens and viral infections. , 1998, Advances in immunology.

[54]  B. Rouse,et al.  Immunopathogenesis of herpetic ocular disease , 1997, Immunologic research.

[55]  F. Alt,et al.  RAG-2-Deficient Blastocyst Complementation , 1994 .

[56]  Moses Rodriguez,et al.  Theiler's murine encephalomyelitis: a model of demyelination and persistence of virus. , 1987, Critical reviews in immunology.

[57]  B. Hogan,et al.  Manipulating the mouse embryo: A laboratory manual , 1986 .

[58]  I. Mackay,et al.  Elicitation of experimental allergic encephalomyelitis (EAE) in mice with the aid of pertussigen. , 1984, Cellular immunology.